Dr. Stephen A. Arrigo, MD

Dr. Arrigo practices at The Bryn Mawr Urology Group in Rosemont, Pennsylvania.

Dr. Arrigo's NPI, 1467496877, was assigned on June 15, 2006. Dr. Arrigo graduated from New York University School of Medicine in 1983. Dr. Arrigo's Pennsylvania license number on file is MD033150E.

Dr. Arrigo's primary practice is The Bryn Mawr Urology Group, at 919 Conestoga Road, Rosemont, PA 19010. The practice phone is (610) 525-6580. Dr. Arrigo also practices at Academic Urology of PA, LLC, 2 Industrial Blvd, Paoli, PA 19301.

Dr. Arrigo's primary practice is The Bryn Mawr Urology Group in Rosemont, Pennsylvania. The medical group on file is MidLantic Urology. Dmand AI also links Dr. Arrigo to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arrigo practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Arrigo's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Arrigo is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Arrigo's licenses on file in 3 states: Pennsylvania, New Jersey and Delaware.

Dmand AI lists prostate cancer radiation among the conditions Dr. Arrigo treats.

CMS data shows 22 Medicare services from Dr. Arrigo across 1 procedure code in 2024, all of them office visits, for 32 Medicare patients. Medicare paid $1,124 for them. Every service was in an office.

CMS counts 32 Medicare patients who saw Dr. Arrigo in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Arrigo's median patient age at 76, with 20% women.

In 2024, Dr. Arrigo wrote 16 Medicare Part D claims. 94% of them were for generic drugs. They cover 2 drugs, with $643 in total drug cost. In 2021, CMS named 41 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Arrigo for performance year 2024, reported as part of a group. Dr. Arrigo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Arrigo, published from 2014 to 2020. 2015 was the busiest year, with 2. Dr. Arrigo has published most often in Front Oncol. Dr. Arrigo's most frequent co-authors are Anthony Ricco, MD, William Ding, MD and Bruce Bart Garber, MD.

CMS Open Payments shows 116 general payments to Dr. Arrigo from 33 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $394.

Dmand AI lists 2 awards for Dr. Arrigo, most recently Regional Top Doctor in 2014.

Dr. Arrigo graduated from New York University School of Medicine in 1983.

Dr. Arrigo is in network with 8 carriers, including Highmark, Cigna and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.